Clinical trials
Myopia trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
122 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 7 |
| 2021 | 4 |
| 2022 | 13 |
| 2023 | 22 |
| 2024 | 14 |
| 2025 | 16 |
| 2026 | 18 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
| Unknown status | 28 |
| Recruiting | 25 |
| Not yet recruiting | 17 |
| Active, not recruiting | 11 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Eye Disease Prevention and Treatment Center | 23 |
| Zhongshan Ophthalmic Center, Sun Yat-sen University | 14 |
| Beijing Tongren Hospital | 10 |
| The Hong Kong Polytechnic University | 10 |
| Sun Yat-sen University | 8 |
| Tianjin Eye Hospital | 7 |
| Beijing Airdoc Technology Co., Ltd. | 5 |
| He Eye Hospital | 3 |
| Ruihua Wei | 3 |
| Wenzhou Medical University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myopia | 122 |
| Refractive Errors | 15 |
| Myopia, Degenerative | 7 |
| Astigmatism | 6 |
| Hyperopia | 4 |
| Eye Diseases | 3 |
| Amblyopia | 2 |
| Lacerations | 2 |
| Asthenopia | 1 |
| Choroid Diseases | 1 |
Trials
Showing 1 to 25 of 122. Each trial links to its page on Pharma Observatory.
22 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.